Abstract: The present invention relates to certain substituted AHR agonist compounds, to pharmaceutical compositions comprising the compounds and to methods of using the compounds to treat immune-mediated diseases.
| # | Name | Date |
|---|---|---|
| 1 | 202417029616-STATEMENT OF UNDERTAKING (FORM 3) [12-04-2024(online)].pdf | 2024-04-12 |
| 2 | 202417029616-REQUEST FOR EXAMINATION (FORM-18) [12-04-2024(online)].pdf | 2024-04-12 |
| 3 | 202417029616-POWER OF AUTHORITY [12-04-2024(online)].pdf | 2024-04-12 |
| 4 | 202417029616-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [12-04-2024(online)].pdf | 2024-04-12 |
| 5 | 202417029616-FORM 18 [12-04-2024(online)].pdf | 2024-04-12 |
| 6 | 202417029616-FORM 1 [12-04-2024(online)].pdf | 2024-04-12 |
| 7 | 202417029616-DECLARATION OF INVENTORSHIP (FORM 5) [12-04-2024(online)].pdf | 2024-04-12 |
| 8 | 202417029616-COMPLETE SPECIFICATION [12-04-2024(online)].pdf | 2024-04-12 |
| 9 | 202417029616-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [12-04-2024(online)].pdf | 2024-04-12 |